Market report
Pharmaceutical tenders in Czechia — market report, February 2025
Pharmaceutical tenders in Czechia in February 2025: 8,674 tenders published (+11% month on month, +33% year on year), estimated at €63,733,516 in total, and 8,691 contracts awarded (+10% month on month, +34% year on year), worth €15,047,523 (awarded value). Buyers with the most tenders: Fakultní nemocnice Bulovka (2,258), Fakultní nemocnice Olomouc (712) and Fakultní nemocnice Brno (704); most contracts won: ViaPharma s.r.o. (292), ROCHE s.r.o. (283) and Janssen-Cilag s.r.o. (182). On average 8.5 bids per contract; 44% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 8,674
- Contracts awarded
- 8,691
- Contract value awarded
- €15,047,523
- Bids per contract
- 8.5
The highlighted bar is February 2025. Hover a bar for its figure; the table below has every value.
| Figure | February 2025 | January 2025 | Change | February 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 8,674 | 7,818 | +11% | 6,500 | +33% |
| Estimated value | €63,733,516 | €26,411,151 | +141% | €448,876,992 | -86% |
| Buyers | 84 | 86 | -2% | 81 | +4% |
| Contracts awarded | 8,691 | 7,885 | +10% | 6,508 | +34% |
| Contract value (awarded) | €15,047,523 | €176,209,101 | -91% | €234,451,902 | -94% |
| Winners | 379 | 372 | +2% | 361 | +5% |
| Bids per contract | 8.5 | 12.2 | — | 1.4 | — |
| Single-bid contracts | 44% | 55% | — | 84% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 292 |
| 2 | ROCHE s.r.o. | 283 |
| 3 | Janssen-Cilag s.r.o. | 182 |
| 4 | Amgen s.r.o. | 154 |
| 5 | Takeda Pharmaceuticals Czech Republic s.r.o. | 132 |
| 6 | Gilead Sciences s.r.o. | 127 |
| 7 | Avenier a.s. | 126 |
| 8 | AbbVie s.r.o. | 122 |
| 9 | Merck Sharp & Dohme s.r.o. | 118 |
| 10 | BAYER s.r.o. | 95 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Medicines and pharmaceuticals
Questions and answers
- How many pharmaceutical tenders were published in Czechia in February 2025?
- 8,674 (by 84 buyers); for comparison, January 2025: 7,818, February 2024: 6,500.
- Who won the most pharmaceutical tenders in Czechia in February 2025?
- By number of contracts: ViaPharma s.r.o. (292), ROCHE s.r.o. (283), Janssen-Cilag s.r.o. (182), Amgen s.r.o. (154) and Takeda Pharmaceuticals Czech Republic s.r.o. (132); 379 companies won contracts in all.
- Which buyers published the most pharmaceutical tenders in February 2025?
- Fakultní nemocnice Bulovka (2,258), Fakultní nemocnice Olomouc (712), Fakultní nemocnice Brno (704), Krajská zdravotní, a.s. (667) and Fakultní Thomayerova nemocnice (436).
- How competitive were pharmaceutical tenders in Czechia in February 2025?
- On average 8.5 bids per contract (124 contracts with a known number of bids); 44% of contracts had a single bid.
- What were the contracts worth in February 2025?
- €15,047,523 (awarded value, 8,691 contracts); median about €55,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.